Warsaw, IN (MMD Newswire) January 28, 2014 — Early results of the limited commercial release of the Re+Line Bunion Correction System were presented during the New York Podiatric Clinical Conference (NYSPMA) held in New York on January 24-26.
Lon S. Weiner, M.D., Chief of Orthopaedic Trauma at Lenox Hill Hospital in New York, presented early clinical results of several of his patients. Dr. Weiner commented, ” The preliminary results with Re+Line are very encouraging. By achieving superior stability, we have observed faster healing, earlier weight bearing and less post-operative pain than with other techniques and implants”. We look forward to further tracking of these positive early patient outcomes”.
The new Re+Line system has obtained FDA clearance and CE mark certification is pending. Re+Line complements the company’s flagship product, the Nextra Hammertoe Correction System. Nextremity Solutions estimates that over 400,000 bunion surgeries were performed in the US in 2013 and that 30-40% of bunion operations are performed together with hammertoe surgery.
Leerink Swann, a leading investment bank, estimates the US bunion surgery market is valued at $240 million. The bunion segment is fragmented with over 130 different techniques reported in the literature. The Re+Line system is designed to provide surgeons with a convenient, single-use kit which combines the Re+Line Bunion Correction Plate with the necessary instruments for a precise bunionectomy with stable fixation and uniform compression.
About Nextremity Solutions, Inc.
Nextremity Solutions is a privately held medical device company offering novel solutions and approaches to the surgical intervention of small bone deformity, degeneration and trauma. The Company’s implant systems for the correction of forefoot pathologies include uniquely precise, proprietary micro-technology designed to achieve repeatable superior clinical outcomes.
For further information, visit www.nextremitysolutions.com or call 574-635-3023.
Nextra Hammertoe Correction System and Nextra Hammertoe Correction Implant are trademarks of Nextremity Solutions, Inc.